[1] [1] BOLAT Z B. The anti-proliferative effect of caffeic acid and dactolisib on human cervical carcinoma HeLa cell line[J]. Cumhuriyet Sci J, 2024, 45(1): 15-19.

[2] [2] FERNANDES F P, CAMBUI R A G, SOARES J L D S, et al. Cervical carcinoma induces NLRP3 inflammasome activation and IL-1 release in human peripheral blood monocytes affecting patients' overall survival[J]. Clin Transl Oncol, 2023, 25(11): 3277-3286.

[4] [4] HU R H, CHEN A M. Inhibitory effect of tanshinone ⅡA nanomicelles on tumor growth and angiogenesis in mice with cervical carcinoma transplantation[J]. Sci Adv Mater, 2023, 15(3): 319-329.

[5] [5] MITRA T, ELANGOVAN S. Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA[J]. Mol Cell Biochem, 2021, 476(12): 4363-4385.

[6] [6] SHAO X Y, BAI L, LIANG J L, et al. Diagnostic value and clinical significance of serum miR-4534 combined with transvaginal color Doppler ultrasound in cervical cancer[J]. Discov Oncol, 2024, 15(1): 403.

[10] [10] DONG Y R, WEN W B, YUAN T Z, et al. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma[J]. Am J Transl Res, 2023, 15(2): 1072-1084.

[11] [11] WANG W, LUO H X, CHANG J J, et al. Circular RNA circ0001955 promotes cervical cancer tumorigenesis and metastasis via the miR-188-3p/NCAPG2 axis[J]. J Transl Med, 2023, 21(1): 356.

[19] [19] YANG H S, LI B, LIU S H, et al. Nomogram model for predicting postoperative survival of patients with stage ⅠB-ⅡA cervical cancer[J]. Am J Cancer Res, 2021, 11(11): 5559-5570.